Sera Prognostics (SERA) FCF Margin Growth (1y) (2021 - 2026)
Sera Prognostics (SERA) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -125.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 2,811.00 |
| 10 | Sera Prognostics | 107.55 Mn | 107.55 Mn | -28,000.00 | -4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.28 Mn |
| Dec 31, 2025 | -3.84 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -911,789.00 |
| Dec 31, 2024 | -957,764.00 |
| Sep 30, 2024 | -606,749.00 |
| Jun 30, 2024 | -1.82 Mn |
| Dec 31, 2023 | -510,672.00 |
| Sep 30, 2023 | -762,677.00 |
| Jun 30, 2023 | 536,795.00 |
| Mar 31, 2023 | 2.02 Mn |
| Dec 31, 2022 | 2.66 Mn |
| Sep 30, 2022 | 3.18 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 2.86 Mn |
| Dec 31, 2021 | 3.24 Mn |
| Sep 30, 2021 | 3.78 Mn |